Literature DB >> 30530299

Retail price and availability of illicit cannabis in Canada.

Syed Mahamad1, David Hammond2.   

Abstract

INTRODUCTION: This study sought to estimate the number of illicit retailers and the average price of cannabis in the largest municipality in each province and territory in Canada by obtaining information from retailers.
METHODS: Online search engines were used to identify retailers in each municipality. The advertised prices for various volumes of the least expensive, most expensive, and most popular dry herb were determined using the retailer's website, Weedmaps, or Leafly. Data was collected between October 2017 and May 2018, including two waves in Toronto to examine changes over a five-month period.
RESULTS: Across the 13 municipalities, 997 cannabis retailers were identified, including 215 physical storefronts. The average price per gram of cannabis was $10.02, $7.80, and $12.30 for the most popular, least expensive, and most expensive strains, respectively. The price-per-gram decreased as purchase volume increased: purchasing one-eighth of an ounce and one ounce of cannabis led to savings of up to 9% and 27%, respectively. Prices were consistent across municipalities, although the number of outlets varied greatly. Prices were similar between storefronts and delivery-only services; however, delivery services offered larger discounts for cannabis purchased by the ounce. The five-month comparison in Toronto revealed modest changes in the number of retailers and more pronounced changes in the price of the most popular and least expensive strains.
CONCLUSION: The findings depict a well-established retail cannabis market in Canada in the year prior to legalization. The average advertised price of the most popular cannabis varieties was approximately $10, which aligns with the projected retail price of cannabis from licensed sources following legalization in Canada.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cannabis; Drug policy; Economics; Legalization; Prices

Mesh:

Substances:

Year:  2018        PMID: 30530299     DOI: 10.1016/j.addbeh.2018.12.001

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  7 in total

1.  Barriers to the wider adoption of medicinal Cannabis.

Authors:  Stephen Ph Alexander
Journal:  Br J Pain       Date:  2020-05-29

2.  Associations of cannabis product source and subsequent cannabis use among adolescents.

Authors:  Annemarie R Kelleghan; Michael J Sofis; Alan Budney; Rachel Ceasar; Adam M Leventhal
Journal:  Drug Alcohol Depend       Date:  2022-02-25       Impact factor: 4.852

Review 3.  Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.

Authors:  Benedikt Fischer; Dimitri Daldegan-Bueno; Joseph M Boden
Journal:  Drug Alcohol Rev       Date:  2020-05-20

4.  Cannabis use and patterns among middle and older aged Canadians prior to legalization: a sex-specific analysis of the Canadian Tobacco, Alcohol and Drugs Survey.

Authors:  Asvini Keethakumar; Vrati M Mehra; Nazilla Khanlou; Hala Tamim
Journal:  BMC Public Health       Date:  2021-01-06       Impact factor: 3.295

5.  Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source.

Authors:  Kirsten Robertson; Maree Thyne
Journal:  Prev Med Rep       Date:  2021-11-16

6.  Cannabis use prior to legalisation among alcohol consumers in the Canadian Yukon and Northwest territories.

Authors:  David Hammond; Samantha Goodman; Erin Hobin
Journal:  Int J Circumpolar Health       Date:  2021-12       Impact factor: 1.228

7.  How High? Trends in Cannabis Use Prior to First Admission to Inpatient Psychiatry in Ontario, Canada, between 2007 and 2017.

Authors:  Taylor McGuckin; Mark A Ferro; David Hammond; Shannon Stewart; Bridget Maloney-Hall; Nawaf Madi; Amy Porath; Christopher M Perlman
Journal:  Can J Psychiatry       Date:  2020-12-31       Impact factor: 4.356

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.